Cover Image


View/Hide Left Panel

Nardin, E.H., R.S.Nussenzweig, I.A.McGregor, and J.H.Bryan. 1979. Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science 206:597–599.

Norrby, E. 1985. Summary. Pp. 387–394 in Vaccines 85. Molecular and Chemical Basis of Resistance to Parasitic, Bacterial, and Viral Diseases, R.A.Lerner, R.M.Chanock, and F.Brown, eds. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratories.

Nussenszweig, R.S., J.Vanderberg, and H.Most. 1969. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium, berghei IV. Dose response, specificity and humoral antibody. Mil. Med. 134(suppl.):1176–1182.

Nussenszweig, R.S., F.Zavala, and V.Nussensweig. 1985. The tandem repeats of the circumsporozoite (CS) protein as a basis for malaria vaccine development. Paper presented at the conference on Modern Approaches to Vaccines, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., Sept. 11–15, 1985.

Perrin, L., A.Perez, and C.Chizzolini. 1984. Malaria, immunity, vaccination and immunodiagnosis. Experimentia 40:1343–1350.

Population Reference Bureau. 1984. 1984 World Population Data Sheet. Washington, D.C.: Population Reference Bureau.

Ravetch, J.V., J.Young, and G.Poste. 1985. Molecular genetic strategies for the development of anti-malarial vaccines. Biotechnology 3:729–740.

Reisberg, B. 1980. Malaria. Pp. 707–716 in The Biologic and Clinical Basis of Infectious Diseases, G.P.Youmans, P.Y.Paterson, and H.M. Sommers, eds. Philadelphia: W.B.Saunders.

Smith, G.L., G.N.Godson, V.Nussenszweig, R.S.Nussenszweig, J. Barnwell, and B.Moss. 1984. Expression of antigenic and iminunogenic Plasmodium knowlesi circumsporozoite protein by an infectious vaccinia virus recombinant. Science 224:397–399.

SPRTTD (Special Programme for Research and Training in Tropical Diseases). 1985. Tropical Disease Research. Seventh Programme Report, 1 January 1983–31 December 1984. Geneva: World Health Organization.

Stürchler, D. 1984. Malaria prophylaxis in travellers: The current position. Experientia 40:1357–1362.

Traeger, W., and T.B.Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673–675.

Walsh, J. 1985. Personal communication, Harvard Medical School, Boston, Mass.

World Health Organization. 1984. World malaria situation, 1982. Rapp. Trimest. Statist. Sanit. Mond. 37:130–161.

Wyler, D.J. 1983. Malaria: Resurgence, resistance and research. N. Engl. J. Med. 308:875–878.

Young, J.F., W.T.Hockmeyer, M.Gross, W.R.Ballou, R.A.Wirtz, J.H.Trosper, R.L.Beaudoin, M.R.Hollingdale, L.H.Miller, C.L. Diggs, and M.Rosenberg. 1985. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science 228:958–962.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement